Reformulated Vaccine Industry Grapples With Scientific, Regulatory, Reimbursement Challenges, But The Promise Is Great

Opportunities are boundless in a resurging vaccines industry, but companies that enter face daunting science and a high regulatory bar as well as unmet needs - old challenges that will only increase for new next-generation products.